Home Companies Glenmark gets DCGI notice over 'false claims', price of Covid drug FabiFlu

Glenmark gets DCGI notice over 'false claims', price of Covid drug FabiFlu

09:19

The 'subject' of the letter was stated as: "Regarding the false claims and pricing of tab FabiFlu 200 mg (favipiravir) by Glenmark Pharmaceuticals Limited, India"

from Companies https://ift.tt/2ZICSfF

No comments:

Subscribe to: Post Comments ( Atom )